Loading company…
London-based biotech founded in 2015 that makes the IRO platform to improve cell and gene therapy manufacturing.
Ori Biotech Ltd, founded in 2015 and headquartered in London, UK, develops manufacturing processes for cell and gene therapies through its cloud-native IRO platform. Its customers include CDMOs, healthcare providers and research institutions. CEO Jason Foster leads the company, which was founded by Farlan Veraitch. In January 2022 it raised GBP 75.92 million in Series B funding from investors including Chimera Investment Corporation and Novalis LifeSciences. It reported revenue of GBP 131,857.10 in 2023.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in